Prevention of visual loss from diabetic retinopathy

Survey of Ophthalmology

Volumn 47, Issue SUPPL. 2, 2002, Pages

  Klein, Ronald ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Diabetes; Diabetic retinopathy; Dyslipidemia; Glycemic control; Hypertension; Visual loss

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LIPID;

ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COST; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; EPIDEMIOLOGICAL DATA; GLUCOSE BLOOD LEVEL; GLYCOSYLATION; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; LASER COAGULATION; LIPID ANALYSIS; MEDICAL SOCIETY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULA EDEMA; VISUAL IMPAIRMENT;

EID: 0036939458     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(02)00388-0     Document Type: Review

References (31)

1. _: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin -dependent diabetes mellitus. N Engl J Med 320:977-86, 1993.
2. _: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837-53, 1998.
3. _: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854-65, 1998.
4. _: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317:703-13, 1998.
5. _: Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. JAMA 276:1409-15, 1996.
6. The absence of a glycemic threshold for the development of long-term complications. the perspective of the Diabetes Control and Complications Trial Diabetes. 45:1996;1289-1298.
7. _: Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Ophthalmology 102:647-61, 1995.
8. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Arch Ophthalmol. 113:1995;36-51.
9. _: A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group. Arch Ophthalmol 108:1234-44, 1990.
10. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 103:1985;1796-1806.
11. _: Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 88:583-600, 1981.
12. Adler A.I., Stratton I.M., Neil H.A.et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36). prospective observational study BMJ. 321:2000;412-419.
13. American Diabetes Association Standards of medical care for patients with diabetes mellitus. Position Statement. Diabetes Care. 24(Suppl 1):2001;533-543.
14. Chaturvedi N. Modulation of the renin-angiotensin system and retinopathy. Heart. 84(Suppl 1):2000;I29-I31.
15. Chaturvedi N, Sjolie AK, Stephenson JM, et al: Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351:28-31, 1998.
16. Chew E.Y., Klein M.L., Ferris F.L. 3rd et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 114:1996;1079-1084.
17. Duncan L.J., Cullen J.F., Ireland J.T.et al. A three-year trial of atromid therapy in exudative diabetic retinopathy. Diabetes. 17:1968;458-467.
18. Early Treatment Diabetic Retinopathy Study Research Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Ophthalmology. 98(Suppl 5):1991;757-765.
19. Estacio R.O., Jeffers B.W., Gifford N., Schrier R.W. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 23(Suppl 2):2000;B54-B64.
20. Gray A., Raikou M., McGuire A.et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes. economic analysis alongside randomised controlled trial (UKPDS 41) United Kingdom Prospective Diabetes Study Group. BMJ. 320:2000;1373-1378.
21. Harris M.I. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care. 23:2000;754-758.
22. Klein B.E., Moss S.E., Klein R., Surawicz T.S. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology. 98:1991;1261-1265.
23. Klein R., Klein B.E., Moss S.E.et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA. 260:1988;2864-2871.
24. Klein R., Klein B.E., Moss S.E., Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVII. The 14- year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes Ophthalmology. 105:1998;1801-1815.
25. Klein R., Klein B.E., Moss S.E., Cruickshanks K.J. The medical management of hyperglycemia over a 10-year period in people with diabetes. Diabetes Care. 19:1996;744-750.
26. Klein R., Klein B.E., Moss S.E., Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long- term incidence of macular edema. Ophthalmology. 102:1995;7-16.
27. Klein R, Klein BEK: Vision disorders in diabetes, in Harris MI, Cowie CC, Stern MP, et al, (eds): Diabetes in America. Washington, DC: US Department of Health and Human Services, National Institutes of Health (NIH) DHHS publication 95-1468, ed 2, pp 293-338.
28. Klein R., Klein B.E., Moss S.E., Cruickshanks K.J. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 154:1994;2169-2178.
29. Knowler W.C., Barrett-Connor E., Fowler S.E.et al. Reduction in the incidence of type 2 diabetes with life-style intervention or metformin. The Diabetes Prevention Research Group. N Engl J Med. 346:2002;393-401.
30. Tuomilehto J., Lindstrom J., Eriksson J.G.et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 344:2001;1343-1350.
31. Witkin S.R., Klein R. Ophthalmologic care for persons with diabetes. JAMA. 251:1984;2534-2537.